Jiangsu Hualan New Pharmaceutical Material Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -10.99% vs 15.01% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -98.37% vs 71.96% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "129.60",
          "val2": "145.60",
          "chgp": "-10.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.90",
          "val2": "31.50",
          "chgp": "-115.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.40",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.50",
          "val2": "3.10",
          "chgp": "-19.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.30",
          "val2": "18.40",
          "chgp": "-98.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-37.70%",
          "val2": "87.50%",
          "chgp": "-12.52%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 5.79% vs -5.88% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 20.77% vs -57.93% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "617.80",
          "val2": "584.00",
          "chgp": "5.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "131.30",
          "val2": "107.70",
          "chgp": "21.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.90",
          "val2": "0.70",
          "chgp": "171.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "8.40",
          "val2": "5.80",
          "chgp": "44.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "59.90",
          "val2": "49.60",
          "chgp": "20.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "81.30%",
          "val2": "56.70%",
          "chgp": "2.46%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

129.60

145.60

-10.99%

Operating Profit (PBDIT) excl Other Income

-4.90

31.50

-115.56%

Interest

0.40

0.00

Exceptional Items

2.50

3.10

-19.35%

Consolidate Net Profit

0.30

18.40

-98.37%

Operating Profit Margin (Excl OI)

-37.70%

87.50%

-12.52%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -10.99% vs 15.01% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -98.37% vs 71.96% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

617.80

584.00

5.79%

Operating Profit (PBDIT) excl Other Income

131.30

107.70

21.91%

Interest

1.90

0.70

171.43%

Exceptional Items

8.40

5.80

44.83%

Consolidate Net Profit

59.90

49.60

20.77%

Operating Profit Margin (Excl OI)

81.30%

56.70%

2.46%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 5.79% vs -5.88% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 20.77% vs -57.93% in Dec 2024

All Annual Results